C-C Chemokine Receptor Type 2 (CCR2) Targeted PET Imaging of Early Atherosclerosis

被引：0
|
作者：
Luehmann, Hannah
Detering, Lisa
Gropler, Robert J.
Liu, Yongjian
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Atherosclerosis; Positron emission tomography; Chemokines; Peptides; Plaque;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20674
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET
    Zhang, Xiaohui
    Qiu, Lin
    Sultan, Debbie H.
    Luehmann, Hannah P.
    Yu, Yanbo
    Zhang, Xiuli
    Heo, Gyu Seong
    Li, Alexandria
    Lahad, Divangana
    Rho, Shinji
    Tu, Zhude
    Liu, Yongjian
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 130-131
  • [2] Chemokine receptor 2 (CCR2) in atherosclerosis, infectious diseases, and regulation of T-cell polarization
    Charo, IF
    Peters, W
    MICROCIRCULATION, 2003, 10 (3-4) : 259 - 264
  • [3] Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis
    Sorensen, TL
    Ransohoff, RM
    Strieter, RM
    Sellebjerg, F
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (07) : 445 - 449
  • [4] C-C Chemokine Receptor 2 Expression by Circulating Monocytes Influences Atherosclerosis in Patients on Chronic Hemodialysis
    Okumoto, Satoshi
    Taniguchi, Yoshihiko
    Nakashima, Ayumu
    Masaki, Takao
    Ito, Takafumi
    Ogawa, Takahiko
    Takasugi, Norihisa
    Kohno, Nobuoki
    Yorioka, Noriaki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2009, 13 (03) : 205 - 212
  • [5] A Novel C-C Chemokine Receptor 2 Antagonist Prevents Progression of Albuminuria and Atherosclerosis in Mouse Models
    Okamoto, Masayuki
    Fuchigami, Masahiro
    Suzuki, Takeshi
    Watanabe, Nobuhide
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2012, 35 (11) : 2069 - 2074
  • [6] Pharmacological Inhibition of C-C Chemokine Receptor 2 Decreases Macrophage Infiltration in the Aortic Root of the Human C-C Chemokine Receptor 2/Apolipoprotein E-/- Mouse: Magnetic Resonance Imaging Assessment
    Olzinski, Alan R.
    Turner, Gregory H.
    Bernard, Roberta E.
    Karr, Heather
    Cornejo, Carla A.
    Aravindhan, Karpagam
    Hoang, Bao
    Ringenberg, Michael A.
    Qin, Pu
    Goodman, Krista B.
    Willette, Robert N.
    Macphee, Colin H.
    Jucker, Beat M.
    Sehon, Clark A.
    Gough, Peter J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 253 - U240
  • [7] Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
    Kalinowska, Alicja
    Losy, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (09) : 1267 - 1279
  • [8] Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice
    Bird, JE
    Giancarli, MR
    Kurihara, T
    Kowala, MC
    Valentine, MT
    Gitlitz, PH
    Pandya, DG
    French, MH
    Durham, SK
    KIDNEY INTERNATIONAL, 2000, 57 (01) : 129 - 136
  • [9] PCSK9 regulates the chemokine receptor CCR2 on monocytes
    Grune, Jana
    Meyborg, Heike
    Bezhaeva, Taisiya
    Kappert, Kai
    Hillmeister, Philipp
    Kintscher, Ulrich
    Pieske, Burkert
    Stawowy, Philipp
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (02) : 312 - 318
  • [10] The influence of chemokine receptor CCR2 genotypes in the route to cervical carcinogenesis
    Coelho, Ana
    Matos, Ana
    Catarino, Raquel
    Pinto, Daniela
    Sousa, Hugo
    Pereira, Deolinda
    Medeiros, Rui
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2007, 64 (04) : 208 - 212
12345